Parkinson’s disease, treatment choice and survival over time

OBJECTIVES: We compared Monoamine oxidase B (MAO-B) – and dopamine agonist (DA) monotherapy patients with respect to survival, considering gender, age, first prescriber’s specialty and relevant co-morbidity, and compared their specialist health care contacts and hospitalizations. METHODS: With data...

Descripción completa

Detalles Bibliográficos
Autores principales: Tvete, I.F., Klemp, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816715/
https://www.ncbi.nlm.nih.gov/pubmed/35146410
http://dx.doi.org/10.1016/j.prdoa.2022.100136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816715/
https://www.ncbi.nlm.nih.gov/pubmed/35146410
http://dx.doi.org/10.1016/j.prdoa.2022.100136

Ejemplares similares